Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 722

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 722
---
91 

Equity
and Equity-Based Plans

Outstanding
Equity Awards at Fiscal Year-End 

The
following table provides information regarding the outstanding equity awards of our named executive officers during the year ended
December 31, 2024.

    Option Awards
     
    Stock Awards

    Name and Principal Position 
     Number of Securities Underlying Unexercised Options Exercisable  
     Number of Securities Underlying Unexercised Options Unexercisable  
     Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options  
     Option Exercise Price  
    Option Expiration Date 
     Number of shares of Common Stock Unvested  
     Market Value of shares of Common Stock Unvested  
     Equity Incentive Plan Awards: Number of Unearned Unvested Shares  
     Equity Incentive Plan Awards: Market or Payout Value of Unearned Unvested Shares 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     17,778  
     4,445  
     —  
    $22.68  
    09/30/2032 
     —  
    $—  
     —  
    $— 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     2,778  
     —  
     —  
     22.68  
    1/10/2033 
     —  
     —  
     —  
     — 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     27,778  
     —  
     —  
     22.68  
    5/15/2033 
     —  
     —  
     —  
     — 

    Francis Knuettel II, Chief Executive Officer and Chief Financial Officer 
     81,000  
     243,000  
     —  
     1.30  
    6/14/2024 
     —  
     —  
     —  
     — 

    Eric Lang, Chief Medical Officer 
     10,093  
     14,130